Amgen announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and only treatment for adults living with Immunoglobulin G4-related disease (IgG4-RD). IgG4-RD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback